pillbase.ru

tislelizumab-jsgr

Active substance: tislelizumab

INJECTION, SOLUTION, CONCENTRATE · TISLELIZUMAB 10 mg/mL

United StatesActive

Marketing holder: Novartis Pharma Stein AG

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Tevimbra
    tislelizumab
    EMEA/H/C/005919
    Beone Medicines Ireland Limited
  • Tizveni
    tislelizumab
    EMEA/H/C/005542
    BeiGene Ireland Ltd
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-67ad-7892-befb-942975ab0858,01a12095-1861-76ae-82bf-b6f398938bf3,01a1209e-68c9-7302-9c25-c4255d775aa5;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
17088-0378
Registration status
Active
Dispensing
Prescription only
Sources
  • product · openFDA NDC · 17088-0378 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 17088-0378 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 17088-0378 · Verified 2026-10-09 · open in source